NICE Medtech Innovation Briefing Supports HemaClear Tourniquet for Bloodless Surgical Field
NICE MIB Supports HemaClear Tourniquet for Bloodless Surgical Field During Limb Surgery
[Click the link above for the full referenced NICE MIB article]
Medtech innovation briefing [MIB187]
We are pleased to announce that the NICE Medtech Innovation Briefing has been completed and published in July in support of our unique all-in-one HemaClear Tourniquet Range for orthopaedic procedures in the surgical environment:
- Bloodless, dry surgical field – avoids risks of incomplete exsanguination
- Reduced incidence of post-op DVT and pulmonary embolism
- 15 second patient setup time with HemaClear® application – Time saving vs traditional methods
The Inefficiencies With Traditional Methods
- Time wasted: Traditional methods require 12 minutes of patient setup time vs. 15 seconds with HemaClear® application
- Inefficiency and aggregate cost of multiple products used during a procedure that employs the pneumatic tourniquet vs. the single-use sterile HemaClear® device.
- OR clutter and shelf space incurred by the pneumatic tourniquet method is eliminated by HemaClear®.
Key features:
- Bloodless, dry surgical field – avoids risks of incomplete exsanguination
- Improved anatomical visibility
- Reduced incidence of post-op DVT
- Reduced incidence of pulmonary embolism
- Reduces blood loss, resulting in decreased need for blood transfusion
If you would like further information on our HemaClear tourniquet range, or would like to request a representative meeting, please complete the form below:
